MY185239A - Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient - Google Patents

Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient

Info

Publication number
MY185239A
MY185239A MYPI2014000895A MYPI2014000895A MY185239A MY 185239 A MY185239 A MY 185239A MY PI2014000895 A MYPI2014000895 A MY PI2014000895A MY PI2014000895 A MYPI2014000895 A MY PI2014000895A MY 185239 A MY185239 A MY 185239A
Authority
MY
Malaysia
Prior art keywords
corneal epithelial
salt
cell death
adenine dinucleotide
epithelial cell
Prior art date
Application number
MYPI2014000895A
Other languages
English (en)
Inventor
Asuka Sakamoto
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of MY185239A publication Critical patent/MY185239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MYPI2014000895A 2011-09-27 2012-09-26 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient MY185239A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011210875 2011-09-27
PCT/JP2012/074662 WO2013047567A1 (ja) 2011-09-27 2012-09-26 フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤

Publications (1)

Publication Number Publication Date
MY185239A true MY185239A (en) 2021-04-30

Family

ID=47995597

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014000895A MY185239A (en) 2011-09-27 2012-09-26 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient

Country Status (8)

Country Link
JP (1) JP5969872B2 (ja)
KR (1) KR20140082699A (ja)
CN (1) CN103826642B (ja)
IN (1) IN2014DN03350A (ja)
MY (1) MY185239A (ja)
SG (2) SG11201400947XA (ja)
TW (1) TWI561238B (ja)
WO (1) WO2013047567A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016046734A2 (en) * 2014-09-22 2016-03-31 University Of The Western Cape Compounds and compositions for treatment of tuberculosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773076B1 (fr) * 1997-12-29 2000-05-19 Chauvin Lab Sa Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec
JP4836401B2 (ja) * 2002-04-01 2011-12-14 ロート製薬株式会社 眼科用組成物
JP2004203836A (ja) * 2002-12-26 2004-07-22 Rohto Pharmaceut Co Ltd 眼科用局所適用製剤
JP2005239622A (ja) * 2004-02-26 2005-09-08 Rohto Pharmaceut Co Ltd 角膜障害治療剤
JP4999304B2 (ja) * 2004-09-27 2012-08-15 ロート製薬株式会社 ヒアルロン酸又はその塩を含有する粘膜適用組成物
JP4969052B2 (ja) * 2005-03-31 2012-07-04 小林製薬株式会社 眼科用組成物
CN101301305A (zh) * 2008-05-14 2008-11-12 北京润德康医药技术有限公司 一种黄素腺嘌呤二核苷酸二钠冻干粉针制剂及其制备方法
JP5506357B2 (ja) * 2009-12-02 2014-05-28 ロート製薬株式会社 シリコーンハイドロゲルコンタクトレンズ用眼科組成物
EP2735303A1 (en) * 2012-11-23 2014-05-28 Pilosciences Hair growth compositions and methods

Also Published As

Publication number Publication date
IN2014DN03350A (ja) 2015-06-05
TW201318628A (zh) 2013-05-16
KR20140082699A (ko) 2014-07-02
SG11201400947XA (en) 2014-07-30
SG10201602401PA (en) 2016-04-28
JP2013082696A (ja) 2013-05-09
TWI561238B (en) 2016-12-11
WO2013047567A1 (ja) 2013-04-04
JP5969872B2 (ja) 2016-08-17
CN103826642B (zh) 2016-02-17
CN103826642A (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
DOP2014000152A (es) Inhibidores de bromodominios
AR088379A1 (es) Formulaciones de etanercept estabilizadas con iones metalicos
CU24424B1 (es) Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2
AU2012214029A8 (en) Rorgammat inhibitors
ECSP13013021A (es) Compuestos de benzotiazol y su uso farmacéutico
EP2755598A4 (en) MANUFACTURE OF GELATIN HYDROGEL SHEET FOR CORNEAL ENDOTHELIUM TRANSPLANTATION
MY167655A (en) Absorbent article
CO6630158A2 (es) Derivados de cetoheteroarilpiperidina y de cetoheteroarilpiperazina como fungicidas
UA111542C2 (uk) Похідне складного ефіру 2-амінонікотинової кислоти та бактерицид, що містить зазначене похідне як активний інгредієнт
CR20140166A (es) Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1
MX359664B (es) Tratamiento de cáncer de mama.
CR20130023A (es) Pirazolo[1,5-a]pirimidinas para tratamiento antiviral
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
MY168300A (en) Pharmaceutical Composition for Inhalation
EP2799537A4 (en) NORMALIZATION OF THE BREEDING OF CORNEAL DENTHELICELLS
NI201300105A (es) Imidazopiridazinas como inhibidores de quinasa akt
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.
MX2014002936A (es) Nuevos derivados de acido betulinico con actividad antiviral.
PH12016501461A1 (en) 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
MY167652A (en) Disposable diaper
IN2014DN10669A (ja)
CR20120521A (es) Combinaciones de principios activos
CR20140213A (es) Preparación de liberación sostenida
MY185239A (en) Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient
MY173442A (en) Method of controlling resistant harmful plants